BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 22556149)

  • 21. An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment.
    Marchetti P; Dotta F; Lauro D; Purrello F
    Regul Pept; 2008 Feb; 146(1-3):4-11. PubMed ID: 17889380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypothesis: Musculin is a hormone secreted by skeletal muscle, the body's largest endocrine organ. Evidence for actions on the endocrine pancreas to restrain the beta-cell mass and to inhibit insulin secretion and on the hypothalamus to co-ordinate the neuroendocrine and appetite responses to exercise.
    Engler D
    Acta Biomed; 2007; 78 Suppl 1():156-206. PubMed ID: 17465332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interventions to improve β-cell mass and function.
    Mondal P; Prasad A; Girdhar K
    Ann Endocrinol (Paris); 2017 Oct; 78(5):469-477. PubMed ID: 28870707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pancreatic beta-cell in human Type 2 diabetes.
    Marchetti P; Del Prato S; Lupi R; Del Guerra S
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16 Suppl 1():S3-6. PubMed ID: 16530127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of glucocorticoids and growth hormone on insulin sensitivity in humans.
    Yuen KC; Chong LE; Riddle MC
    Diabet Med; 2013 Jun; 30(6):651-63. PubMed ID: 23510125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of serum pancreatic derived factor (PANDER) with beta-cell dysfunction in type 2 diabetes mellitus.
    Shehata MM; Kamal MM; El-Hefnawy MH; El-Mesallamy HO
    J Diabetes Complications; 2017 Apr; 31(4):748-752. PubMed ID: 28161382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Insulin secretion and insulin resistance].
    Ohta Y; Tanizawa Y
    Nihon Rinsho; 2013 Nov; 71(11):1936-40. PubMed ID: 24397162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta Cell Function and the Nutritional State: Dietary Factors that Influence Insulin Secretion.
    Moore WT; Bowser SM; Fausnacht DW; Staley LL; Suh KS; Liu D
    Curr Diab Rep; 2015 Oct; 15(10):76. PubMed ID: 26294335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Insulin resistance and islet beta cell function in type 2 diabetes mellitus and non alcoholic fatty liver disease.].
    Li FP; Zhang SQ; Wang F; Huang YQ; Fu ZZ; Yan L
    Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):940-3. PubMed ID: 20079327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin resistance causes increased beta-cell mass but defective glucose-stimulated insulin secretion in a murine model of type 2 diabetes.
    Asghar Z; Yau D; Chan F; Leroith D; Chan CB; Wheeler MB
    Diabetologia; 2006 Jan; 49(1):90-9. PubMed ID: 16362284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel approaches to drug discovery for the treatment of type 2 diabetes.
    Xu X; Wang G; Zhou T; Chen L; Chen J; Shen X
    Expert Opin Drug Discov; 2014 Sep; 9(9):1047-58. PubMed ID: 25054271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormalities in insulin secretion in type 2 diabetes mellitus.
    Guillausseau PJ; Meas T; Virally M; Laloi-Michelin M; Médeau V; Kevorkian JP
    Diabetes Metab; 2008 Feb; 34 Suppl 2():S43-8. PubMed ID: 18640585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. β-Cell adaptation in a mouse model of glucocorticoid-induced metabolic syndrome.
    Fransson L; Franzén S; Rosengren V; Wolbert P; Sjöholm Å; Ortsäter H
    J Endocrinol; 2013 Dec; 219(3):231-41. PubMed ID: 24048967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocorticoids Reprogram β-Cell Signaling to Preserve Insulin Secretion.
    Fine NHF; Doig CL; Elhassan YS; Vierra NC; Marchetti P; Bugliani M; Nano R; Piemonti L; Rutter GA; Jacobson DA; Lavery GG; Hodson DJ
    Diabetes; 2018 Feb; 67(2):278-290. PubMed ID: 29203512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The endoplasmic reticulum stress response in the pancreatic β-cell.
    Volchuk A; Ron D
    Diabetes Obes Metab; 2010 Oct; 12 Suppl 2():48-57. PubMed ID: 21029300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autophagy and pancreatic β-cells.
    Mazza S; Maffucci T
    Vitam Horm; 2014; 95():145-64. PubMed ID: 24559917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exercise and inactivity as modifiers of β cell function and type 2 diabetes risk.
    Hall LG; Thyfault JP; Johnson JD
    J Appl Physiol (1985); 2023 Apr; 134(4):823-839. PubMed ID: 36759159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen and exercise may enhance beta-cell function and mass via insulin receptor substrate 2 induction in ovariectomized diabetic rats.
    Choi SB; Jang JS; Park S
    Endocrinology; 2005 Nov; 146(11):4786-94. PubMed ID: 16037383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of sugar-sweetened beverage intake on the development of type 2 diabetes mellitus in subjects with impaired glucose tolerance: the Mihama diabetes prevention study.
    Teshima N; Shimo M; Miyazawa K; Konegawa S; Matsumoto A; Onishi Y; Sasaki R; Suzuki T; Yano Y; Matsumoto K; Yamada T; Gabazza EC; Takei Y; Sumida Y
    J Nutr Sci Vitaminol (Tokyo); 2015; 61(1):14-9. PubMed ID: 25994135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Development and Analysis of Novel Therapeutic Targets to Improve Pancreatic β-Cell Function in Type 2 Diabetes].
    Kaneko YK
    Yakugaku Zasshi; 2016; 136(12):1623-1629. PubMed ID: 27904096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.